Author:
BORA POPY,SAIKIA BISHAL,RAHMAN MEHJEBIN,AHMED SHENAZ SULTANA,CHETIA RAJASHREE,RAHMAN NASEEMA,NATH BHARAT CH,RAJA WASIM HASSAN
Abstract
Considering the majority of studies confined in vitro evaluation of microbial bioagents against diseases, a study was carried out during 2018–21 at Assam Agricultural University, Jorhat, Assam, (in vivo and field studies) to assess bio-efficacy of B. subtilis (strain LB22)-based liquid bioformulation against bacterial wilt (Ralstonia solanacearum) and anthracnose (Colletotrichum gloeosporioides) diseases of chilli (Capsicum annuum L.). In vivo efficacy of B. subtilis formulation (inclusive treatment involving seed treatment, seedling dip, soil treatment and foliar spray) showed significant suppressiveness against both the diseases coupled with enhanced growth and yield attributes. Subsequently, the field evaluation of Bacillus subtilis formulation comparing standard chemicals also edged over the latter by 15.45% in terms of yield gains in 2-years of study. A significant reduction was found in disease severity during field evaluation of Bacillus subtilis formulation on account of induced resistance via upregulated synthesis of plant defense-enzymes (Polyphenol oxidase, peroxidase, phenylalanine ammonia-lyase, and β-1,3-glucanase) by 2.3–11.0 folds with their peaks mostly expressed within 24–72 h. These results put forward a conceptual framework for delivery mechanism of a microbial bioagent in a formulation mode, having the potential to be effective against a number of other diseases as well.
Publisher
Indian Council of Agricultural Research, Directorate of Knowledge Management in Agriculture
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献